In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis

In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis

Osteoporosis treatment with PTH 1-34 injections significantly reduces the incidence of bone fracture. Potential further reductions in fracture rate should be observed through nasal spray delivery to address the poor compliance associated with patient dislike of repeated PTH 1-34 subcutaneous injecti...

Full description

Bibliographic Details
Main Authors: Williams, Allan J., Jordan, Faron, King, Gareth, Lewis, Andrew L., Illum, Lisbeth, Masud, Tahir, Perkins, Alan C., Pearson, Richard G.
Format: Article
Published: Elsevier 2017
Subjects:
Osteoporosis
teriparatide
formulation
nasal spray
osteoblast
drug delivery
Online Access:https://eprints.nottingham.ac.uk/47418/

Internet

https://eprints.nottingham.ac.uk/47418/

Similar Items